New: Maxis AI Workforce now live across clinical operations.Learn more →

Maxis AI — THE FIRST AI WORKFORCE IN CLINICAL TRIALS
For Large CRO

Agentic AI for Large CRO

Improve study margins and delivery predictability with supervised AI execution.

Large CROs face a core delivery constraint: capacity scales with headcount, and biometrics cost grows faster than margin.

Maxis AI delivers a supervised execution layer that increases throughput without proportional staffing — strengthening margins while improving sponsor-facing oversight.

Human-in-the-loop validation · Audit traceability

STUDY MARGIN UPLIFT
45%
Q1
52%
Q2
50%
Q3
68%
Q4
82%
Q1+
94%
Q2+
Margin per study
+49% vs baseline
Agentic AI Offerings

Our platform strengthens execution across key clinical workflows.

AI Data Quality and RBQM Hub

  • Unified portfolio-level oversight
  • Continuous data quality monitoring
  • Reduced manual data review effort

AI-Driven Clinical Data Management

  • Automated data cleaning and validation
  • Faster database readiness timelines

AI-Powered Statistical Programming

  • Automated dataset preparation
  • Improved biometrics efficiency

Portfolio Oversight and Governance

  • Continuous monitoring across trials
  • Stronger delivery visibility
Operational Pressure

Where Large CRO Delivery Often Slows

Execution constraints commonly occur due to:

High manual data review effort

Increasing biometrics staffing costs

Limited visibility across sponsor portfolios

Database readiness delays

Margin pressure as delivery scales

Outcomes

What Improves with Agentic AI

With agentic AI solutions for large contract research organizations, delivery becomes more scalable.

Reduced biometrics workload

Faster database readiness timelines

Improved portfolio-level visibility

Stronger operational governance

Improved delivery margins

Recommended Approach

Deploy the AI Workforce for Data Quality and RBQM first. This simultaneously reduces biometrics cost and establishes the portfolio-level oversight capability required in sponsor RFPs.

Case Study

100+ Programs. Margins Protected. No Headcount Growth Required.

Growth was scaling, but biometrics delivery still depended on more headcount. See how a global CRO improved portfolio execution and cross-study RBQM visibility.

$200–400K

Savings per trial

8–12 Wks

RBQM risk advance warning

70%

Programming automation

0 FTE

Additional headcount needed

FAQ

All You Need to Know

They improve biometrics efficiency and reduce manual workload.

Yes. Supervised execution increases biometrics throughput without proportional headcount scaling, reducing cost per study and improving delivery margins.

Yes. It strengthens execution capacity.

Data management and biometrics workflows.

Yes. It supports large, multi-sponsor portfolios.

Looking for Agentic AI for clinical trials?

Explore the Agentic AI Platform.

See how AI agents are transforming study startup, data management, oversight, and regulatory submissions.